Prevención no farmacológica de la neumonía asociada a ventilación mecánica

Translated title of the contribution: Non-Pharmacological Prevention of Ventilator Associated Pneumonia

Luis Aurelio Díaz, Mireia Llauradó, Jordi Rello, Marcos I. Restrepo

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


Ventilator-associated pneumonia (VAP) is the first cause of mortality due to nosocomial infections in the intensive care unit. Its incidence ranges from 9% to 67% of patients on mechanical ventilation. Risk factors are multiple and are associated with prolonged stays in hospital and intensive care units. Additional costs for each episode of VAP range from 9,000 y to 31,000 €. Thus, its prevention should be considered as a priority. This prevention could decrease associated morbidity, mortality, costs, and increase patient safety.

Translated title of the contributionNon-Pharmacological Prevention of Ventilator Associated Pneumonia
Original languageSpanish
Pages (from-to)188-195
Number of pages8
JournalArchivos de Bronconeumologia
Issue number4
StatePublished - Apr 2010


  • Artificial respiration
  • Cross infection
  • Disease prevention
  • Intensive care unit
  • Ventilator-associated pneumonia

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Non-Pharmacological Prevention of Ventilator Associated Pneumonia'. Together they form a unique fingerprint.

Cite this